ClinicalTrials.gg
RecruitingNCT05983692Updated Nov 12, 2026

High-purity Magnesium (99.99%) Wire for Augmentation of ACL Reconstruction

An interventional study of Magnesium based wire in Anterior Cruciate Ligament Rupture, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2024; still recruiting 2 years 6 months later.
Updated Nov 12, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Anterior Cruciate Ligament Injuries by Chinese University of Hong Kong — 4 open to participants now, 5 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · Chinese University of Hong Kong.

Started
2024
the only one that year
No phase
7 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Anterior Cruciate Ligament Injuries by Chinese University of Hong Kong, this one is the only one that started in 2024, is one of 7 with no phase, and was the 10th registered.

Anterior Cruciate Ligament Injuries

627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

4 of the 10 studies in Anterior Cruciate Ligament Injuries by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Anterior Cruciate Ligament Injuries by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

Background: ACLR with autologous tendon graft is commonly used for the treatment of ACL injury. However, as the BTI healing is poor, this can lead to a failure rate of 5% in the first-year post-operation; a long and unpredictable rehabilitation period is expected and 35 % of patients never return to preinjury level of sports. Biological enhancement of BTI healing will help to cut down the medical cost related to poor prognosis. As a biodegradable metal, Magnesium (Mg) has been developed as implants in orthopaedics for decades, yet without clinical implants developed for ACLR. Our team has been working on this area in the past 10 years preclinically. Our animal studies showed that supplementation of magnesium wire significantly promotes osteogenesis at BTI and improves mechanical strength in ACLR. Recently, our team developed a highly pure (99.99%) Mg wire (Fig 2) in collaboration with metallic engineers for tendon graft braiding during ACLR and with its improved physical quality and strength, it is suitable for graft braiding and then its degradation in vivo can promote tunnel bone formation and bone tendon interface integration.

Objective: To investigate if anterior cruciate ligament (ACL) reconstruction augmented with magnesium (Mg) wire enhances osteogenesis at the bone-tendon interface (BTI), improving post-op rehabilitation and leading to better clinical outcomes.

Hypothesis: Patients with ACL reconstruction using Mg wire will experience improved osteogenesis at the BTI, more effective rehabilitation, and superior knee strength and function.

Design and Subjects: A multicentre, double-blinded, randomized controlled trial will recruit patients aged 18-30 with unilateral ACL tear for primary ACLR with a hamstring graft at four sites.

Instruments: Mg-based wire.

Interventions: Participants will receive either 99.99% purity Mg wire or 2-0 vicryl as a control.

Main Outcomes: Osteogenesis will be assessed by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT), muscle strength via Biodex tests, and functional recovery with International Knee Documentation Committee (IKDC) and Tegner scores at multiple post-op intervals. Knee stability will be checked with KT-1000 arthrometer. Blood samples will be analyzed for inflammatory markers and metabolic effects related to Mg wire.

Data Analysis and Expected Results: A repeated-measures ANOVA will be utilized for data analysis. The expectation is that Mg wire augmentation will significantly enhance osteogenesis at the BTI and improve rehabilitation outcomes.

03

Conditions studied

  • Anterior Cruciate Ligament Rupture

Keywords

  • ACLR
  • Mg wire
  • Bone tendon interface healing
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-40
  • Unilateral ACL tear for primary ACLR (Single bundle, Hamstring) confirmed clinically and radiologically.

Exclusion criteria

Exclusion Criteria:

  • Concomitant multiple ligament injuries requiring additional surgical procedures,
  • Preoperative radiographic signs of arthritis,
  • Revision ACLR
  • Femoral tunnel interference screws
  • Contralateral knee with ACL deficiency or reconstruction
  • Medical co-morbidities
  • Long-term intake
  • Non-compliance to our rehabilitation protocol.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Mg Wire group

    Intervention: 99.99% Magnesium wire as braiding suture to braid the tendon graft.

    Device: Magnesium based wire

  • No intervention
    control group

    2-0 vicryl suture as control, size and length matched Mg wire

Interventions

  • DeviceMagnesium based wire

    Mg wire will be used as a braiding suture to braid tendon graft, which is a standard preparation of graft and is not related to fixation of the tendon graft

06

What researchers measure

Primary outcomes

  1. Bone shell size

    HR-pQCT (ExtremCT II, Scanco, Switzerland) will be used to measure the bone shell size at graft tunnel interface. The involved knees will be investigated. A total of 1344 axial slices with an image matrix of 2304 × 2304 were collected at a nominal isotropic voxel size of 60.7μm. The scan region was defined by the scout view image acquired in the sagittal plane.The total scanning length was 81.6mm which covered the tunnel from proximal tibia to distal femoral condyle (X-ray settings: 68kVp, 1470μA, 100ms integration time, 156mAs per stack (168 slices).Image segmentation will be performed to select the bone shell features at graft tunnel interfaces near femoral and tibial intra-articular apertures with standardized threshold values at a thickness of \~2.5 mm (40 slices). Geometric transformation will be performed to adjust for the variations in angle between scanning axis and tunnel axis by a cosine function.

    Time frame: 2 weeks and 3, 6, 12 and 24 months post-operation.

Secondary outcomes

  1. International Knee Documentation Committee

    Consists of 10 questions on symptoms and activity ranging from 0 to 100 where 100 implies perfect knee function.

    Time frame: Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.

  2. Tegner activity score

    This is an activity level scaled from 1 (low activity) to 10 (high activity).

    Time frame: Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.

  3. Passive Knee laxity

    To measure anterior-posterior knee laxity, the KT-1000 knee ligament arthrometer (MEDmetric Corp, San Diego, CA, USA) will be used. A manual force test will be applied until a 30lb sound signal is activated. Three trials will be performed. A side difference of 3 mm above is considered clinically relevant.

    Time frame: 3, 6, 12 and 24 months post-operation.

  4. Isokinetic muscle strength

    The dynamometer (Biodex System 4, Biodex Medical Systems Inc., New York, USA) will be used for measuring Isokinetic muscle strength in N. Subjects will perform a standardized warm-up exercise (5 min cycling) followed by the test. Concentric/concentric contractions of knee extension/flexion will be tested at 60°/s and 180°/s. Subjects will be seated on the dynamometer chair with their hips flexed to 85°.

    Time frame: 3, 6, 12 and 24 months post-operation

  5. Cytokines assay

    To evaluate the safety of Mg wire with respect to inflammatory responses, 5 ml blood samples will be collected for C-reactive protein measurement using ELISA kit. Measurements of Ca, Mg, P, Cr, Urea, ALT, AST, TP, ALB, GLB will be taken to monitorpotential effect of the Mg wire. The blood tests will be performed at baseline, day 1 post-op, 2 weeks, 6 weeks and 12 weeks post-op, since the degradation of Mg wire is faster based on our preclinical study results.

    Time frame: Pre-operation, Day 1, 2 and 6 weeks and 3 months post-operation

  6. Single leg hop distance

    The average of single leg hop distance in cm with three attempts will be measured during the single leg hop test.

    Time frame: 6, 12 and 24 months post-operation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: starting 6 months after publication

Access criteria: Journal reviewers

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Sep 2027, 40 months after the start.

Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 40 months is above that.

Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: start Jun 2024 → May 2024, primary completion Sep 2026 → Sep 2027 and completion Sep 2027 → Nov 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2023
First posted
Aug 9, 2023
StartActual
May 16, 2024was Jun 2024
Primary completionEst.
Sep 2027was Sep 2026
CompletionEst.
Nov 2027was Sep 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 12, 2026
Sites
The Chinese University of Hong Kong is now Recruiting
Nov 12, 2026
Start date
Jun 2024→May 16, 2024 (actual)
Nov 12, 2026
Primary completion
Sep 2026→Sep 2027
Nov 12, 2026
Study completion
Sep 2027→Nov 2027
Nov 12, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • The Chinese University of Hong Kong · Hong Kong, Hong KongContact added m•••@cuhk.edu.hk · •••4171
Nov 12, 2026
Title
MgHigh-purity Magnesium (99.99%) Wire for Augmentation of ACL Reconstruction
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Not yet recruiting→Recruiting
    The Chinese University of Hong Kong is now Recruiting
    Start date Jun 2024→May 16, 2024 (now actual)
    Primary completion Sep 2026→Sep 2027
    Study completion Sep 2027→Nov 2027
    Site contacts Changed at 1 site. See the sites
    Show the site
    • The Chinese University of Hong Kong · Hong Kong, Hong KongContact added m•••@cuhk.edu.hk · •••4171
    Title MgHigh-purity Magnesium (99.99%) Wire for Augmentation of ACL Reconstruction
    + 3 other changes: verification date, description and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05983692
Collaborators
Alice Ho Miu Ling Nethersole Hospital, Kwong Wah Hospital, Tseung Kwan O Hospital, Hong Kong
Responsible party
Prof. Tim-Yun Michael ONG (Clinical Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Aug 9, 2023
Start date
May 16, 2024
Primary completion
Sep 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Michael Tim-Yun Ong
Contact
michael.ong@cuhk.edu.hk
055699059

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion